Skip to content
  • About us
    • Advisory Board
    • Our mission
    • GDPR Policy
  • Editorial guidelines
    • Peer-review protocol
    • Author guidelines
    • Editorial Calendar 2018
    • Editorial Calendar 2017
  • Advertise with us
    • Media Information 2021
    • Media Information 2020
  • Subscribe
    • weekly newsletter
  • Contact Us
secondary menu
Journal for Clinical Studies
Journal for Clinical StudiesJournal for Clinical Studies
 

  • Home
  • Current features/ Volume 13 Issue 1
  • Editorial Archive
    • Volume 12 Issue 6
    • Volume 12 Issue 5
    • Volume 12 Issue 4
    • Volume 12 Issue 3
    • Volume 12 Issue 2
    • Volume 12 Issue 1
    • Volume 11 Issue 6
    • Volume 11 Issue 5
    • Volume 11 Issue 4
    • Volume 11 Issue 3
    • Volume 11 Issue 2
    • Volume 11 Issue 1
    • Volume 10 Issue 6
    • Volume 10 Issue 5
    • Volume 10 Issue 4
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 6
      • Volume 10 Issue 6
    • Volume 9 Issue 5
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 9 Issue 1
      • Regulatory V9 I1
      • Market Report V9 I1
      • Therapeutics V9 I1
      • IT & Logistics V9 I1
    • Volume 8 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Technology
      • Therapeutics
      • Special Features
      • Logistics
    • Volume 8 Issue 5
      • Watch Pages V8 I5
      • Regulatory V8 I5
      • Market Report V8 I5
      • Technology V8 I5
      • Therapeutics V8 I5
      • Special Features V8 I5
      • Logistics V8 I5
    • Volume 8 Issue 4
      • Watch Pages V8 I4
      • Regulatory V8 I4
      • Market Report V8 I4
      • Therapeutics V8 I4
      • Technology V8 I4
      • Logistics V8 I4
      • Special Feature V8 I4
    • Volume 8 Issue 3
      • Watch Pages V8 I3
      • Regulatory V8 I3
      • Market Report V8 I3
      • Therapeutics V8 I3
      • Technology V8 I3
      • Logistics V8 I3
      • Special Feature V8 I3
    • Volume 8 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 8 Issue 1
    • Volumen 8 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 issue 3
      • Watch Pages
      • Therapeutics
      • Research & Development
      • Regulatory & Marketplace
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 7 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 6 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • It & Logistics
      • Special Features
    • Volume 6 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 5 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • It & Logistics
      • Therapeutics
      • Special Features
    • Volume 5 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 5 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Feature
    • Volume 5 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
  • Archived Issues
  • Industry events
  • Company Profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Regional News
    • Asia Pacific
    • Australasia
    • Europe
    • Latin America
    • MEANA Region
    • North America
    • Russia/Eastern Europe
    • Scandinavia
    • South Africa
    • Sub Saharan Africa
  • eBooks
  • Podcast
  • Home
  • Current features/ Volume 13 Issue 1
  • Editorial Archive
    • Volume 12 Issue 6
    • Volume 12 Issue 5
    • Volume 12 Issue 4
    • Volume 12 Issue 3
    • Volume 12 Issue 2
    • Volume 12 Issue 1
    • Volume 11 Issue 6
    • Volume 11 Issue 5
    • Volume 11 Issue 4
    • Volume 11 Issue 3
    • Volume 11 Issue 2
    • Volume 11 Issue 1
    • Volume 10 Issue 6
    • Volume 10 Issue 5
    • Volume 10 Issue 4
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 6
      • Volume 10 Issue 6
    • Volume 9 Issue 5
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 9 Issue 1
      • Regulatory V9 I1
      • Market Report V9 I1
      • Therapeutics V9 I1
      • IT & Logistics V9 I1
    • Volume 8 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Technology
      • Therapeutics
      • Special Features
      • Logistics
    • Volume 8 Issue 5
      • Watch Pages V8 I5
      • Regulatory V8 I5
      • Market Report V8 I5
      • Technology V8 I5
      • Therapeutics V8 I5
      • Special Features V8 I5
      • Logistics V8 I5
    • Volume 8 Issue 4
      • Watch Pages V8 I4
      • Regulatory V8 I4
      • Market Report V8 I4
      • Therapeutics V8 I4
      • Technology V8 I4
      • Logistics V8 I4
      • Special Feature V8 I4
    • Volume 8 Issue 3
      • Watch Pages V8 I3
      • Regulatory V8 I3
      • Market Report V8 I3
      • Therapeutics V8 I3
      • Technology V8 I3
      • Logistics V8 I3
      • Special Feature V8 I3
    • Volume 8 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 8 Issue 1
    • Volumen 8 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 issue 3
      • Watch Pages
      • Therapeutics
      • Research & Development
      • Regulatory & Marketplace
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 7 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 6 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • It & Logistics
      • Special Features
    • Volume 6 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 5 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • It & Logistics
      • Therapeutics
      • Special Features
    • Volume 5 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 5 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Feature
    • Volume 5 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
  • Archived Issues
  • Industry events
  • Company Profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Regional News
    • Asia Pacific
    • Australasia
    • Europe
    • Latin America
    • MEANA Region
    • North America
    • Russia/Eastern Europe
    • Scandinavia
    • South Africa
    • Sub Saharan Africa
  • eBooks
  • Podcast

Tag Archives: Phase 2

Janssen to begin phase 2 clinical trials of Hanmi Pharma’s diabetes drug

Asia Pacific, EuropeBy flabio54th April 2018

US pharmaceutical company Janssen will start carrying out phase 2 clinical trials in the US to evaluate the efficacy and…

LaJolla Pharma launches mid-stage study of LJPC-401 in iron overload disorder

newsBy flabio520th December 2017

LaJolla Pharmaceuticals initiates a Phase 2 clinical trial assessing LJPC-401 (synthetic human hepcidin) in patients with hereditary hemochromatosis, a deficiency of…

Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel

newsBy flabio514th December 2017

Hovione announced today enrollment of the first patient in MARS (Minocycline Against Rosacea Study), a Phase 2 clinical study of…

Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma

newsBy flabio513th December 2017

Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive topline results from a pivotal Phase 2 clinical study of…

© 2020 Jforcs Media, All Rights Reserved. Powered by Teksyte LTD
Go to Top